Yonglian Zeng

机构：Guangxi University, Guangxi Medical University, First Affiliated Hospital of GuangXi Medical University · ORCID：0000-0003-1846-5706

发表论文 36 篇 · 总被引 515 次 · h-index 13

代表论文

• Complement C3 activation regulates the production of tRNA-derived fragments Gly-tRFs and promotes alcohol-induced liver injury and steatosis (2019 · Cell Research · 被引 110)
• Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice (2022 · Frontiers in Immunology · 被引 40)
• Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma (2019 · World Journal of Gastroenterology · 被引 33)
• Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning (2023 · Frontiers in Immunology · 被引 26)
• FGD1 exhibits oncogenic properties in hepatocellular carcinoma through regulating cell morphology, autophagy and mitochondrial function (2020 · Biomedicine & Pharmacotherapy · 被引 23)
• Tetramethylpyrazine ameliorates hepatic fibrosis through autophagy-mediated inflammation (2020 · Biochemistry and Cell Biology · 被引 21)